Learn About Breztri, the New Triple-Therapy Inhaler for Severe COPD

November 2022

Breztri Aerosphere will be the latest “3-in-1” inhaler for COPD.

It combines two long-acting inhaled bronchodilators, formoterol and glycopyrronium...along with the corticosteroid budesonide.

Think of Breztri as similar to the other triple-therapy inhaler for COPD, Trelegy Ellipta. But Breztri is a metered-dose inhaler that’s 2 puffs bid...Trelegy is a dry-powder inhaler that’s 1 puff daily.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Emergency Preparedness Be Ready to Navigate Med Issues During a Disaster or Emergency
Immunizations Prevent Errors With COVID-19 Boosters and Flu Vaccinations
COPD Learn About Breztri, the New Triple-Therapy Inhaler for Severe COPD
Contraceptives Elevate Your Understanding of Emergency Contraception
Controlled Substances Prevent, Detect, and Respond to Internal Diversion
Anticoagulants Use Strategies to Improve Safety With Warfarin
Needles & Syringes Point Out Differences Among Pen Needles
Heart Failure Stay Alert for Meds That Can Exacerbate Heart Failure
Hormone Therapy Minimize Mix-Ups With Menopausal Hormone Therapy

Learn About Breztri, the New Triple-Therapy Inhaler for Severe COPD

Practical advice for a better career, with unlimited access to CE

Table of Contents